Sinemet CR in Parkinson's disease.

R. F. Pfeiffer, K. E. Wilken, C. S. Glaeske, R. Hofman

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Sinemet CR, a controlled release carbidopa/levodopa preparation, was compared to conventional carbidopa/levodopa in a double blind, placebo-controlled trial. Comparable clinical benefits and adverse effects were noted with the two medications. However significantly less frequent dosing was necessary with Sinemet CR.

Original languageEnglish (US)
Pages (from-to)8-10
Number of pages3
JournalThe Nebraska medical journal
Issue number1
StatePublished - Jan 1991

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Sinemet CR in Parkinson's disease.'. Together they form a unique fingerprint.

Cite this